535-0030-00L Pharmaceutical Immunology II & Therapeutic Proteins
| Semester | Herbstsemester 2023 |
| Dozierende | C. Halin Winter, D. Neri |
| Periodizität | jährlich wiederkehrende Veranstaltung |
| Lehrsprache | Englisch |
| Kommentar | Als Voraussetzung muss entweder die 535-0830-00L Pharmaceutical Immunology I oder 551-0317-00L Immunologie I besucht worden sein. |
Lehrveranstaltungen
| Nummer | Titel | Umfang | Dozierende | ||||
|---|---|---|---|---|---|---|---|
| 535-0030-00 G | Pharmaceutical Immunology II & Therapeutic Proteins | 3 Std. |
| C. Halin Winter, D. Neri |
Katalogdaten
| Kurzbeschreibung | In this course, various topics related to the development, GMP production and application of therapeutic proteins will be discussed. Furthermore, students will expand their training in pharmaceutical immunology and will be introduced to the basic concepts of pharmaceutical product quality management. | ||||||||||||||||||
| Lernziel | Students know and understand: - basic mechanisms and regulation of the immune response - the pathogenic mechanisms of the most important immune-mediated disorders - the concepts of vaccination and cancer immunotherapy - the most frequently used expression systems for the production of therapeutic proteins - the use of protein engineering tools for modifying different features of therapeutic proteins - the mechanism of action of selected therapeutic proteins and their application - basic concepts in the GMP production of therapeutic proteins | ||||||||||||||||||
| Inhalt | The course consists of two parts: In the first part, students will complete their training in Pharmaceutical Immunology. This part particularly focuses on the pathogenic mechanisms of immune-mediated diseases, vaccination and cancer immunotherapy. Deepened knowledge of immunology will be relevant for understanding the mechanism of action of many therapeutic proteins, as well as for understanding one major concern related to the use of protein-based drugs, namely, immunogenicity. The second part focuses on topics related to the development and application of therapeutic proteins, such as protein expression, protein engineering, reducing immunogenicity, and GMP production of therapeutic proteins. Furthermore, selected examples of approved therapeutic proteins will be discussed. | ||||||||||||||||||
| Skript | Handouts to the lectures will be available for downloading under http://www.pharma.ethz.ch/scripts/index | ||||||||||||||||||
| Literatur | - Janeway's ImmunoBiology, by Kenneth Murphy (9th or 10th Edition) - Lecture Handouts - Paper References provided in the Scripts - EMEA Dossier for Humira | ||||||||||||||||||
| Voraussetzungen / Besonderes | Prerequisites: Either 535-0830-00L Pharmaceutical Immunology I or 551-0317-00L Immunology I | ||||||||||||||||||
Kompetenzen |
|
Leistungskontrolle
| Information zur Leistungskontrolle (gültig bis die Lerneinheit neu gelesen wird) | |
Leistungskontrolle als Semesterkurs | |
| ECTS Kreditpunkte | 3 KP |
| Prüfende | C. Halin Winter, D. Neri |
| Form | Sessionsprüfung |
| Prüfungssprache | Englisch |
| Repetition | Die Leistungskontrolle wird in jeder Session angeboten. Die Repetition ist ohne erneute Belegung der Lerneinheit möglich. |
| Prüfungsmodus | mündlich 15 Minuten |
| Diese Angaben können noch zu Semesterbeginn aktualisiert werden; verbindlich sind die Angaben auf dem Prüfungsplan. | |
Lernmaterialien
| Keine öffentlichen Lernmaterialien verfügbar. | |
| Es werden nur die öffentlichen Lernmaterialien aufgeführt. |
Gruppen
| Keine Informationen zu Gruppen vorhanden. |
Einschränkungen
| Vorrang | Die Belegung der Lerneinheit ist nur durch die primäre Zielgruppe möglich |
| Primäre Zielgruppe | Pharmazie (Eidg. Diplom für Apoth.) MSc (510200)
Pharmaceutical Sciences MSc (512000) Biochemie - Chemische Biologie MSc (513000) DAS ETH Vorbereit. eidg. Prüfung in Pharmazie (A) (540000) DAS ETH Vorbereit. eidg. Prüfung in Pharmazie (B) (540100) |